The study was approved by the institutional review board, and all patients were registered with the Comprehensive Cancer Center of Wake Forest University (CCCWFU) Protocol Registrar. Informed consent was obtained prior to the pre-enrollment medical screening. Pre-enrollment medical screening was used to determine the patient’s eligibility. This study was conducted in compliance with the ethical standards of the responsible institution on human subjects as well as with the Helsinki Declaration.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.